Literature DB >> 15172400

Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experience.

Raymond L Benza1, Gilbert J Zoghbi, Jose Tallaj, Robert Brown, James K Kirklin, Meloneysa Hubbard, Barry Rayburn, Brian Foley, David C McGiffin, Laura J Pinderski, Vijay Misra, Robert C Bourge.   

Abstract

OBJECTIVES: The goal of this study was to examine the outcomes of percutaneous coronary interventions (PCI) and the predictors for restenosis after cardiac transplantation.
BACKGROUND: The role of PCI as definitive therapy for allograft coronary disease (ACD) remains contentious.
METHODS: Between January 1, 1990 and December 31, 2000, 62 patients (1.5 to 15.5 years after transplant) underwent 151 procedures resulting in PCIs of 219 lesions. Follow-up after PCI angiography was usually obtained at three and six months, then yearly. Repeat PCI was routinely done to lesions with >60% restenosis.
RESULTS: The primary procedural success was 97%. Repeat PCI occurred in 74 of 219 lesions (34%); PCI-related mortality was 2.6% (4 of 151). The freedom from re-PCI (of same vessel site) was 75% at six months, 65% at one year, and 57% at four years. The freedom from restenosis was 95% at one month, 81% at three months, and 57% at six months. Multivariate predictors of freedom from restenosis were the use of stents, higher anti-proliferative immunosuppressant dose, and an era effect. In the setting of one-vessel disease at first PCI, the two-year freedom for ACD death or graft loss was 74%, compared with 75% for two-vessel and 27% for three-vessel disease (p = 0.009).
CONCLUSIONS: Despite the increasing effectiveness of PCI for localized ACD, the survival after development of advanced ACD remains poor. Stents appear to increase effectiveness of PCI for ACD, but other factors in the current era contribute to improved outcomes.

Entities:  

Mesh:

Year:  2004        PMID: 15172400     DOI: 10.1016/j.jacc.2004.02.045

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

1.  Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study.

Authors:  Michele Pighi; Fabrizio Tomai; Alessandro Petrolini; Leonardo de Luca; Giuseppe Tarantini; Alberto Barioli; Paola Colombo; Silvio Klugmann; Marco Ferlini; Maurizio Ferrario Ormezzano; Bruno Loi; Paolo Calabrò; Renato Maria Bianchi; Giuseppe Faggian; Alberto Forni; Corrado Vassanelli; Marco Valgimigli; Flavio Ribichini
Journal:  J Cardiovasc Transl Res       Date:  2015-12-18       Impact factor: 4.132

2.  Diagnostic and prognostic value of myocardial perfusion gated SPECT in orthotopic heart transplant recipients.

Authors:  Alain Manrique; Mathieu Bernard; Anne Hitzel; Michael Bubenheim; Christophe Tron; Denis Agostini; Alain Cribier; Pierre Véra; Jean Paul Bessou; Michel Redonnet
Journal:  J Nucl Cardiol       Date:  2010-02-12       Impact factor: 5.952

Review 3.  Diagnosis and management of coronary allograft vasculopathy in children and adolescents.

Authors:  Nathalie Dedieu; Gerald Greil; James Wong; Matthew Fenton; Michael Burch; Tarique Hussain
Journal:  World J Transplant       Date:  2014-12-24

4.  Omission of Heart Transplant Recipients From the Appropriate Use Criteria for Revascularization and the Ramifications on Heart Transplant Centers.

Authors:  Joe X Xie; Jon A Kobashigawa; Kevin F Kennedy; Timothy D Henry; Steven W Tabak; Robert Krebbs; Leslee Shaw; J Dawn Abbott; Wendy Book; S Tanveer Rab; John A Spertus; Abhinav Goyal
Journal:  JAMA Cardiol       Date:  2020-06-01       Impact factor: 14.676

Review 5.  Cardiac allograft vasculopathy: the Achilles' heel of long-term survival after cardiac transplantation.

Authors:  Amandeep Dhaliwal; Vinay Thohan
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

6.  Evolving concepts and treatment strategies for cardiac allograft vasculopathy.

Authors:  Rodolfo Denadai Benatti; David O Taylor
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01

7.  Alterations in the fibrinolytic cascade post-transplant: evidence of a bimodal expression pattern.

Authors:  Raymond L Benza; Matthew A Cavender; Joseph Barchue; Jose A Tallaj; Robert C Bourge; James K Kirklin; Christopher S Coffey
Journal:  J Heart Lung Transplant       Date:  2007-05       Impact factor: 10.247

8.  Detection of significant coronary artery stenosis with 64-slice computed tomography in heart transplant recipients: a comparative study with conventional coronary angiography.

Authors:  Franz von Ziegler; Alexander W Leber; Alexander Becker; Ingo Kaczmarek; Ulf Schönermarck; Christine Raps; Janine Tittus; Peter Uberfuhr; Christoph R Becker; Maximilian Reiser; Gerhard Steinbeck; Andreas Knez
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-19       Impact factor: 2.357

Review 9.  Endothelial dysfunction and cardiac allograft vasculopathy.

Authors:  Monica Colvin-Adams; Nonyelum Harcourt; Daniel Duprez
Journal:  J Cardiovasc Transl Res       Date:  2012-11-08       Impact factor: 4.132

Review 10.  Outcomes and survival following heart retransplantation for cardiac allograft failure: a systematic review and meta-analysis.

Authors:  Syed-Saif Abbas Rizvi; Jessica G Y Luc; Jae Hwan Choi; Kevin Phan; Ester Moncho Escrivà; Sinal Patel; H Todd Massey; Vakhtang Tchantchaleishvili
Journal:  Ann Cardiothorac Surg       Date:  2018-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.